Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children.

Mark R Withers,Denise McKinney,Bernhards R Ogutu,John N Waitumbi,Jessica B Milman,Odika J Apollo, Otieno G Allen,Kathryn Tucker,Lorraine A Soisson,Carter Diggs,Amanda Leach,Janet Wittes,Filip Dubovsky,V Ann Stewart,Shon A Remich,Joe Cohen,W Ripley Ballou,Carolyn A Holland,Jeffrey A Lyon,Evelina Angov,José A Stoute,Samuel K Martin,D Gray Heppner

PLoS clinical trials（2006）

Cited 70|Views8
No score
Abstract
The FMP1/AS02A vaccine was safe and immunogenic in malaria-exposed 12- to 47-mo-old children and the magnitude of immune response of the 25 and 50 microg doses was superior to that of the 10 microg dose.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined